A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

April 30, 2006

Study Completion Date

May 29, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Combined lifestyle intervention and optimisation of pharmacological treatment

"1. 6 months non-pharmacological treatment, 18 months with polypharmacy for glucose control (metformin, repaglinide/glimepiride, pioglitazone or insulin)~2. standard care"

Trial Locations (1)

1309

Asker and Baerum Hospital, Medical Department, Rud

All Listed Sponsors
collaborator

Rikshospitalet University Hospital

OTHER

collaborator

University Hospital, Aker

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

lead

Asker & Baerum Hospital

OTHER

NCT00133718 - A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control | Biotech Hunter | Biotech Hunter